The Use of Dual Energy Computerized Tomography to Detect Residual Viable Hepatocellular Carcinoma after Transarterial Chemoembolization

Objective: To determine the value of the dual energy computerized tomography (DECT) for detection of residual viable hepatocellular carcinoma (HCC) after transarterial chemoembolization (TACE). Methods: Single-source (ss) DECT of liver was performed in adult patients who were diagnosed as HCC and t...

Full description

Bibliographic Details
Main Authors: Pharida Pengwan, M.D., Voraparee Suvannarerg, M.D., Aphinya Charoensak, M.D.
Format: Article
Language:English
Published: Mahidol University 2019-05-01
Series:Siriraj Medical Journal
Subjects:
Online Access:http://www.smj.si.mahidol.ac.th/sirirajmedj/index.php/smj/article/view/2833/2690
id doaj-14315e8ef0a145e7be28b00be1f76650
record_format Article
spelling doaj-14315e8ef0a145e7be28b00be1f766502020-11-25T01:18:01ZengMahidol UniversitySiriraj Medical Journal2228-80822019-05-0171320721310.33192/Smj.2019.32The Use of Dual Energy Computerized Tomography to Detect Residual Viable Hepatocellular Carcinoma after Transarterial ChemoembolizationPharida Pengwan, M.D.0Voraparee Suvannarerg, M.D.1Aphinya Charoensak, M.D.2Department of Radiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.Department of Radiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.Department of Radiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.Objective: To determine the value of the dual energy computerized tomography (DECT) for detection of residual viable hepatocellular carcinoma (HCC) after transarterial chemoembolization (TACE). Methods: Single-source (ss) DECT of liver was performed in adult patients who were diagnosed as HCC and treated with TACE at Siriraj Hospital during October 1st, 2013- December 31st, 2014. The diagnostic 5-point performance score of conventional liver CT imaging set (CCTI) and iodinated material density imaging set (IMDI) obtained simultaneously by using DECT, were evaluated by two radiologists. The follow up imaging at 6 months was regarded as gold standard. The sensitivity and specificity were calculated by assigned score 4 or 5 lesions as positive for the presence of HCC, assigned score 1 or 2 lesions as negative for viable tumor and assigned score 3 lesions as uncertain diagnosis. McNemar’s test was used to compare the sensitivity and specificity between CCTI and IMDI. The reading time of both technique and radiation dose were recorded and the mean reading time were compared using a paired t-test. Results: Out of total 21 patients with 66 lesions, 81% were male and 19% were female with mean age 61.8 ± 10.2 years old. After monitoring for 6 months, 35 of the total 66 lesions were still viable HCCs and 31 lesions became non-viable HCCs. CCTI had excellent inter-observer agreement while IMDI had moderate agreement (K = 0.931 and 0.534, respectively). The sensitivity of CCTI and IMDI for detection of viable tumor were 88.6% and 100%, respectively (p-value cannot be computed). The specificity of CCTI and IMDI were 96.8% and 93.5%, respectively (p-value = 1.000). The mean reading time of two radiologists for CCTI was 151.2 ± 134.7 seconds and 123.2 ± 126.8 seconds for IMDI (p-value = 0.048). Total radiation dose of dynamic liver CT was 1194.22 ± 179.44 mGy cm. Conclusion: IMDI has higher sensitivity for detection of viable HCCs after TACE and consumes less reading time than CCTI.http://www.smj.si.mahidol.ac.th/sirirajmedj/index.php/smj/article/view/2833/2690Dual energy CTviable HCCtransarterial chemoembolization
collection DOAJ
language English
format Article
sources DOAJ
author Pharida Pengwan, M.D.
Voraparee Suvannarerg, M.D.
Aphinya Charoensak, M.D.
spellingShingle Pharida Pengwan, M.D.
Voraparee Suvannarerg, M.D.
Aphinya Charoensak, M.D.
The Use of Dual Energy Computerized Tomography to Detect Residual Viable Hepatocellular Carcinoma after Transarterial Chemoembolization
Siriraj Medical Journal
Dual energy CT
viable HCC
transarterial chemoembolization
author_facet Pharida Pengwan, M.D.
Voraparee Suvannarerg, M.D.
Aphinya Charoensak, M.D.
author_sort Pharida Pengwan, M.D.
title The Use of Dual Energy Computerized Tomography to Detect Residual Viable Hepatocellular Carcinoma after Transarterial Chemoembolization
title_short The Use of Dual Energy Computerized Tomography to Detect Residual Viable Hepatocellular Carcinoma after Transarterial Chemoembolization
title_full The Use of Dual Energy Computerized Tomography to Detect Residual Viable Hepatocellular Carcinoma after Transarterial Chemoembolization
title_fullStr The Use of Dual Energy Computerized Tomography to Detect Residual Viable Hepatocellular Carcinoma after Transarterial Chemoembolization
title_full_unstemmed The Use of Dual Energy Computerized Tomography to Detect Residual Viable Hepatocellular Carcinoma after Transarterial Chemoembolization
title_sort use of dual energy computerized tomography to detect residual viable hepatocellular carcinoma after transarterial chemoembolization
publisher Mahidol University
series Siriraj Medical Journal
issn 2228-8082
publishDate 2019-05-01
description Objective: To determine the value of the dual energy computerized tomography (DECT) for detection of residual viable hepatocellular carcinoma (HCC) after transarterial chemoembolization (TACE). Methods: Single-source (ss) DECT of liver was performed in adult patients who were diagnosed as HCC and treated with TACE at Siriraj Hospital during October 1st, 2013- December 31st, 2014. The diagnostic 5-point performance score of conventional liver CT imaging set (CCTI) and iodinated material density imaging set (IMDI) obtained simultaneously by using DECT, were evaluated by two radiologists. The follow up imaging at 6 months was regarded as gold standard. The sensitivity and specificity were calculated by assigned score 4 or 5 lesions as positive for the presence of HCC, assigned score 1 or 2 lesions as negative for viable tumor and assigned score 3 lesions as uncertain diagnosis. McNemar’s test was used to compare the sensitivity and specificity between CCTI and IMDI. The reading time of both technique and radiation dose were recorded and the mean reading time were compared using a paired t-test. Results: Out of total 21 patients with 66 lesions, 81% were male and 19% were female with mean age 61.8 ± 10.2 years old. After monitoring for 6 months, 35 of the total 66 lesions were still viable HCCs and 31 lesions became non-viable HCCs. CCTI had excellent inter-observer agreement while IMDI had moderate agreement (K = 0.931 and 0.534, respectively). The sensitivity of CCTI and IMDI for detection of viable tumor were 88.6% and 100%, respectively (p-value cannot be computed). The specificity of CCTI and IMDI were 96.8% and 93.5%, respectively (p-value = 1.000). The mean reading time of two radiologists for CCTI was 151.2 ± 134.7 seconds and 123.2 ± 126.8 seconds for IMDI (p-value = 0.048). Total radiation dose of dynamic liver CT was 1194.22 ± 179.44 mGy cm. Conclusion: IMDI has higher sensitivity for detection of viable HCCs after TACE and consumes less reading time than CCTI.
topic Dual energy CT
viable HCC
transarterial chemoembolization
url http://www.smj.si.mahidol.ac.th/sirirajmedj/index.php/smj/article/view/2833/2690
work_keys_str_mv AT pharidapengwanmd theuseofdualenergycomputerizedtomographytodetectresidualviablehepatocellularcarcinomaaftertransarterialchemoembolization
AT vorapareesuvannarergmd theuseofdualenergycomputerizedtomographytodetectresidualviablehepatocellularcarcinomaaftertransarterialchemoembolization
AT aphinyacharoensakmd theuseofdualenergycomputerizedtomographytodetectresidualviablehepatocellularcarcinomaaftertransarterialchemoembolization
AT pharidapengwanmd useofdualenergycomputerizedtomographytodetectresidualviablehepatocellularcarcinomaaftertransarterialchemoembolization
AT vorapareesuvannarergmd useofdualenergycomputerizedtomographytodetectresidualviablehepatocellularcarcinomaaftertransarterialchemoembolization
AT aphinyacharoensakmd useofdualenergycomputerizedtomographytodetectresidualviablehepatocellularcarcinomaaftertransarterialchemoembolization
_version_ 1725144254249959424